JEIL PHARMA HOLDINGS INC.(KR:002620)
₩6,870.00+80.00 (+1.18%)
KR:002620
JEIL PHARMA HOLDINGS INC. financials statements
₩6,870.00
At close:+80.00 (+1.18%)
Want to see KR:002620 full AI Analyst Report?
JEIL PHARMA HOLDINGS INC. (002620) Income Statement
JEIL PHARMA HOLDINGS INC. Income Statement
Last quarter (Q2 2026), JEIL PHARMA HOLDINGS INC.'s total revenue was ₩166.63B, an increase of 4.29% from the same quarter last year. In Q2, JEIL PHARMA HOLDINGS INC.'s net income was ₩-3.55B. See JEIL PHARMA HOLDINGS INC.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ₩ 657.61B | ₩ 779.82B | ₩ 804.04B | ₩ 792.96B | ₩ 762.57B | |
| ₩ 226.27B | ₩ 206.52B | ₩ 214.58B | ₩ 180.48B | ₩ 180.51B | |
| ₩ 211.20B | ₩ 218.08B | ₩ 193.66B | ₩ 188.03B | ₩ 189.48B | |
| Depreciation and Amortization | ₩ 14.95B | ₩ 14.10B | ₩ 12.56B | ₩ 10.91B | ₩ 8.98B |
| ₩ 30.02B | ₩ -38.65B | ₩ 9.25B | ₩ -67.00B | ₩ 6.14B | |
| ₩ 15.07B | ₩ -11.56B | ₩ 20.92B | ₩ -7.55B | ₩ 1.55B | |
| ₩ 24.29B | ₩ -50.07B | ₩ -34.90B | ₩ -76.31B | ₩ 2.85B | |
| ₩ 39.55B | ₩ -61.63B | ₩ -13.98B | ₩ -83.86B | ₩ -6.13B | |
| ₩ 14.64B | ₩ -51.16B | ₩ -16.25B | ₩ -83.15B | ₩ -12.87B | |
| Per Share Metrics | |||||
| Basic EPS | ₩ 953.37 | ₩ -3323.31 | ₩ -1059.00 | ₩ -5416.22 | ₩ -838.38 |
| Diluted EPS | ₩ 953.37 | ₩ -3323.31 | ₩ -1058.54 | ₩ -5416.22 | ₩ -838.38 |
| Weighted Average Shares Outstanding | 15.97M | 15.35M | 15.34M | 15.35M | 15.35M |
| Weighted Average Shares Outstanding (Diluted) | 15.97M | 15.35M | 15.35M | 15.35M | 15.35M |
Currency in KRW
